Dual GIPR and GLP-1R agonist tirzepatide inhibits aeroallergen-induced allergic airway inflammation in mouse model of obese asthma
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:53 |
|---|---|
| Enthalten in: |
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology - 53(2023), 2 vom: 25. Feb., Seite 216-221 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Toki, Shinji [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
59392-49-3 |
|---|
| Anmerkungen: |
Date Completed 17.02.2023 Date Revised 23.01.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/cea.14252 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM348910592 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM348910592 | ||
| 003 | DE-627 | ||
| 005 | 20240123231827.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/cea.14252 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1268.xml |
| 035 | |a (DE-627)NLM348910592 | ||
| 035 | |a (NLM)36377605 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Toki, Shinji |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Dual GIPR and GLP-1R agonist tirzepatide inhibits aeroallergen-induced allergic airway inflammation in mouse model of obese asthma |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.02.2023 | ||
| 500 | |a Date Revised 23.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, U.S. Gov't, Non-P.H.S. | |
| 650 | 4 | |a GIP | |
| 650 | 4 | |a GLP-1 | |
| 650 | 4 | |a Th2 | |
| 650 | 4 | |a incretin mimetic drugs | |
| 650 | 4 | |a obese asthma | |
| 650 | 4 | |a tirzepatide | |
| 650 | 7 | |a tirzepatide |2 NLM | |
| 650 | 7 | |a OYN3CCI6QE |2 NLM | |
| 650 | 7 | |a Gastric Inhibitory Polypeptide |2 NLM | |
| 650 | 7 | |a 59392-49-3 |2 NLM | |
| 700 | 1 | |a Zhang, Jian |e verfasserin |4 aut | |
| 700 | 1 | |a Printz, Richard L |e verfasserin |4 aut | |
| 700 | 1 | |a Newcomb, Dawn C |e verfasserin |4 aut | |
| 700 | 1 | |a Cahill, Katherine N |e verfasserin |4 aut | |
| 700 | 1 | |a Niswender, Kevin D |e verfasserin |4 aut | |
| 700 | 1 | |a Peebles, R Stokes |c Jr |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology |d 1990 |g 53(2023), 2 vom: 25. Feb., Seite 216-221 |w (DE-627)NLM012617121 |x 1365-2222 |7 nnns |
| 773 | 1 | 8 | |g volume:53 |g year:2023 |g number:2 |g day:25 |g month:02 |g pages:216-221 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/cea.14252 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 53 |j 2023 |e 2 |b 25 |c 02 |h 216-221 | ||